中国药物警戒 ›› 2026, Vol. 23 ›› Issue (4): 375-382.
DOI: 10.19803/j.1672-8629.20260132

• 高原睡眠-觉醒障碍的病证结合动物模型与中药干预研究专栏 • 上一篇    下一篇

高原日间功能障碍痰浊蒙窍证动物模型的构建与评价

戚凌1,2, 张娴勰1,2#, 陈熙泰1,2, 黄天科2, 李芳1,2, 陈丽苹2, 拓艳玲2, 马增春1,2,*   

  1. 1广东药科大学药学院,广东 广州 510006;
    2军事科学院军事医学研究院,北京 100850
  • 收稿日期:2026-02-11 出版日期:2026-04-15 发布日期:2026-04-15
  • 通讯作者: *马增春,男,博士,副研究员,中药药理与毒理学。E-mail: mazchun@139.com。#为共同通信作者。
  • 作者简介:戚凌,女,在读硕士,药学。
  • 基金资助:
    国家自然科学基金资助项目(82474196); 中医药能力提升项目(2023ZY063)

Establishment and Evaluation of an Animal Model for High-Altitude Daytime Dysfunction with Syndrome of Phlegm-Turbidity Obstructing the Orifices

QI Ling1,2, ZHANG Xianxie1,2#, CHEN Xitai1,2, HUANG Tianke2, LI Fang1,2, CHEN Liping2, TA Yanling2, MA Zengchun1,2,*   

  1. 1School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou Guangdong 510006, China;
    2Academy of Military Medical Sciences, Beijing 100850, China
  • Received:2026-02-11 Online:2026-04-15 Published:2026-04-15

摘要: 目的 探索高原日间功能障碍痰浊蒙窍证动物模型,为高原特殊环境下日间功能障碍的病理机制研究与药物筛选奠定研究基础。方法 在模型筛选实验中,将C57BL/6J小鼠分为对照组(NC)、睡眠剥夺干预因素为主的睡眠剥夺-低压低氧组(SD3-HH0组、SD3-HH1组、SD3-HH2组)、低压低氧干预因素为主的低压低氧-睡眠剥夺组(HH3-SD0组、HH3-SD1组、HH3-SD2组)以及HH3-SD3组,每组12只。通过观察体重变化、血常规指标及组织病理学改变,综合筛选最佳造模条件。在模型评价实验中,将C57BL/6J小鼠随机分为对照组(NC)、模型组(HH3-SD1)、咖啡因组(CAF,15 mg·kg-1)和乙酰唑胺组(ACZ,100 mg·kg-1),每组12只,给药组于实验前2天开始每日灌胃,连续给药至实验结束,模型组与对照组给予同体积生理盐水。另取4只SD大鼠采用自身对照法进行睡眠脑电监测。通过睡眠-觉醒脑电监测、行为学测试(抓力实验、Morris水迷宫)、转录组测序及ELISA等技术,综合评价模型动物的日间功能状态与中医证候特征。结果 构建以模拟海拔5 500 m低压低氧暴露72 h,并于最后24 h复合旋转式睡眠剥夺(42 s/正反旋转一圈)的高原日间功能障碍痰浊蒙窍证动物模型,表现为睡眠结构紊乱(总觉醒时长减少,总睡眠时长增加)、疲劳状态加重、学习记忆能力下降,同时出现血脑屏障损伤、HPA轴亢进、氧化应激与炎症反应增强、BDNF及单胺类神经递质水平降低;转录组分析显示下丘脑昼夜节律通路与海马PI3K-Akt等信号通路显著富集。结论 高原日间功能障碍动物模型能够模拟高原环境下痰浊蒙窍证的临床表现与病理特征,具有较好的病理表型与中医证候相关性,为高原日间功能障碍病理机制研究及开展药物筛选与药效评价提供实验参考。

关键词: 高原日间功能障碍, 痰浊蒙窍证, 动物模型, 睡眠剥夺, 低压低氧, 中医证候, 大鼠, 小鼠

Abstract: Objective To establish and evaluate an animal model of high-altitude daytime dysfunction with the Traditional Chinese Medicine (TCM) syndrome of “phlegm-turbidity obstructing the orifices” in order to provide data for research on the pathological mechanisms and for screening therapeutic drugs for daytime dysfunction in high-altitude environments. Methods In the model screening experiment, C57BL/6J mice were divided into a control group (NC), sleep deprivation intervention groups (SD3-HH0, SD3-HH1, SD3-HH2), hypobaric hypoxia intervention groups (HH3-SD0, HH3-SD1, HH3-SD2), and the HH3-SD3 group, with 12 mice in each group. Optimal modeling conditions were selected by observing body weight changes, blood routine parameters, and histopathological alterations. In the model evaluation experiment, C57BL/6J mice were randomly divided into a control group (NC), a model group (HH3-SD1), a caffeine group (CAF, 15 mg·kg-1), and an acetazolamide group (ACZ, 100 mg·kg-1), with 12 mice in each group. The treatment groups received daily intragastric administration that started 2 days before the experiment and continued until the end of the experiment while the model and control groups received an equivalent volume of normal saline. In addition, SD rats (n=4) were used for sleep EEG monitoring via a self-control method. The daytime functional status and TCM syndrome of the model animals were evaluated via sleep-wake EEG monitoring, behavioral tests (grip strength test, Morris water maze), transcriptome sequencing, and ELISA techniques. Results An animal model of high-altitude daytime dysfunction with the syndrome of “phlegm-turbidity obstructing the orifices” was established by exposing rats to hypobaric hypoxia equivalent to 5 500 meters for 72 hours, with rotating sleep deprivation (one full rotation every 42 seconds, in alternating directions) during the final 24 hours. The model animals showed disrupted sleep architecture (decreased total waking hours, increased total sleep time), aggravated fatigue, and impaired learning and memory abilities. Concurrently, pathological changes included blood-brain barrier damage, hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis, enhanced oxidative stress and inflammatory responses, and decreased levels of brain-derived neurotrophic factor (BDNF) and monoamine neurotransmitters. Transcriptome analysis revealed significant enrichment of the circadian rhythm pathway in the hypothalamus and the PI3K-Akt signaling pathway in the hippocampus. Conclusion The established animal model of high-altitude daytime dysfunction can effectively simulate the clinical manifestations and pathological features of the “phlegm-turbidity obstructing the orifices” syndrome under high-altitude conditions. It reveals a good correlation between pathological phenotypes and manifestations of this TCM syndrome, providing a reliable experimental platform for studying the pathological mechanisms of high-altitude daytime dysfunction and for conducting drug screening and efficacy evaluation.

Key words: High-Altitude Daytime Dysfunction, Syndrome of Phlegm-Turbidity Obstructing the Orifices, Animal Model, Sleep Deprivation, Hypobaric Hypoxia, Traditional Chinese Medicine Syndrome, Rats, Mice

中图分类号: